Literature DB >> 7733289

Production and metabolism of dopamine and norepinephrine in mesenteric organs and liver of swine.

G Eisenhofer1, A Aneman, D Hooper, C Holmes, D S Goldstein, P Friberg.   

Abstract

Concentrations of catecholamines and their metabolites in plasma entering and exiting mesenteric organs, liver, and kidneys were examined to assess the regional production and metabolism of catecholamines in anesthetized swine. Higher portal venous than arterial plasma concentrations of norepinephrine and its metabolites, 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG), and of dopamine and its metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), indicated substantial production of both catecholamines by mesenteric organs, representing 45-50% of total body production. Most dopamine was not metabolized to norepinephrine, suggesting a large nonnoradrenergic contribution to total body dopamine production. Concentrations of norepinephrine, DHPG, normetanephrine, and MHPG were lower in plasma exiting than entering the liver, whereas concentrations of the end-product of norepinephrine metabolism, vanillylmandelic acid (VMA), were higher in outflowing than inflowing plasma. Over 94% of the VMA removed by the kidneys was produced in the liver, consistent with the hepatic source of this metabolite. Removal of DOPAC and HVA by the liver exceeded removal by the kidneys or production by mesenteric organs, indicating greater hepatic than renal elimination of these metabolites from the body and underestimation of mesenteric organ dopamine production based on summed spillovers of dopamine metabolites from the liver into the systemic circulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733289     DOI: 10.1152/ajpgi.1995.268.4.G641

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

Review 1.  Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.

Authors:  G Eisenhofer; T T Huynh; M Hiroi; K Pacak
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.

Authors:  Thamara E Osinga; Thera P Links; Robin P F Dullaart; Karel Pacak; Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Ido P Kema
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

Review 3.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

4.  Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity.

Authors:  Lydia M M Vermeer; Virginia R Florang; Jonathan A Doorn
Journal:  Brain Res       Date:  2012-07-31       Impact factor: 3.252

5.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

6.  The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit.

Authors:  B Friedgen; R Wölfel; H Russ; E Schömig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

7.  A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine.

Authors:  E Mezey; G Eisenhofer; G Harta; S Hansson; L Gould; B Hunyady; B J Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  The inhibitory effect of ghrelin on sepsis-induced inflammation is mediated by the MAPK phosphatase-1.

Authors:  Asha Jacob; Derry Rajan; Betsy Pathickal; Imran Balouch; Adam Hartman; Rongqian Wu; Mian Zhou; Ping Wang
Journal:  Int J Mol Med       Date:  2010-01       Impact factor: 4.101

9.  Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension.

Authors:  Melissa Li; Xiaoling Dai; Stephanie Watts; David Kreulen; Gregory Fink
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-03       Impact factor: 3.619

10.  Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol.

Authors:  Jennifer N Rees; Virginia R Florang; Laurie L Eckert; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2009-07       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.